Kenya tests new way to get HIV prevention pills to 17,000 pregnant women
NCT ID NCT06526507
First seen Feb 01, 2026 · Last updated Jun 22, 2026 · Updated 23 times
Summary
This study aims to help Kenyan clinics offer PrEP (HIV prevention pills) to pregnant and postpartum women more effectively. Researchers will provide clinics with a training toolkit, quality improvement support, and a community of practice for staff. The goal is to see if this package increases the number of women screened for and started on PrEP during routine maternal and child health visits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Busia County Referral Hospital
Busia, Kenya
-
Kapsabet County Referral Hospital
Kapsabet, Nandi, Kenya
-
Kenyatta National Hospital
Nairobi, MRX5 + 53, Kenya
-
Kitale County Referral Hospital
Kitale, Trans Nzoia, Kenya
-
Uasin Gishu District Hospital
Eldoret, Uasin Gishu County, Kenya
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Implementation strategy package (training, quality improvement, and community of practice)
What this could lead to
If successful, this could make it easier for thousands of pregnant and postpartum women in Kenya to get HIV prevention medication, reducing new infections.
What could go wrong
This is a large-scale implementation study, not a test of a new drug. Success depends on real-world factors like staff turnover and clinic resources, so results may vary across sites.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.